These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2523342)

  • 21. PPOs: rejuvenating Medicare.
    Wheeler G
    Med Interface; 1996 Jan; 9(1):49-50. PubMed ID: 10153790
    [No Abstract]   [Full Text] [Related]  

  • 22. Operational and legal implications of preferred provider organizations.
    Adams-Ryan D; Peddecord KM; Root GL
    Hosp Health Serv Adm; 1985; 30(3):44-57. PubMed ID: 10271468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying incremental cost in HMO/PPO bid evaluation.
    Annis RJ; Holton JW
    Health Prog; 1986 Apr; 67(3):26-8. PubMed ID: 10275904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of injecting price competition into the hospital market: the case of preferred provider organizations.
    Dranove D; Satterthwaite M; Sindelar J
    Inquiry; 1986; 23(4):419-31. PubMed ID: 2947862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective contracting in California: experience in the second year.
    Johns L; Anderson MD; Derzon RA
    Inquiry; 1985; 22(4):335-47. PubMed ID: 2934329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPO option will attract Medicare beneficiaries to integrated systems.
    Health Care Strateg Manage; 1995 Mar; 13(3):3. PubMed ID: 10141214
    [No Abstract]   [Full Text] [Related]  

  • 27. Is the Medicare SELECT program a stepping-stone to managed care?
    Kolb DS; Belt JE
    Healthc Financ Manage; 1997 Oct; 51(10):54, 56-7. PubMed ID: 10173964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlling utilization through a selective participation PPO.
    Pesillo CO
    Empl Benefits J; 1994 Jun; 19(2):15-7. PubMed ID: 10134135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Provider-based Medicare risk contracting and subcontracting: opportunities and risks for provider sponsored organizations.
    Levin HA; Zenner PA; Kipp RA; Whitney EL
    Manag Care Q; 1997; 5(4):18-33. PubMed ID: 10175717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of preferred provider organizations on health care use and costs.
    Smith DG
    Inquiry; 1997-1998 Winter; 34(4):278-87. PubMed ID: 9472227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When is it time to walk away from an HMO/PPO contract? How to analyze the financial impact of alternative delivery systems on hospitals.
    Turner BN; Valentine ST
    Healthc Forum J; 1989; 32(2):13-6. PubMed ID: 10292195
    [No Abstract]   [Full Text] [Related]  

  • 32. Combating silent PPOs.
    Belt JE; Ryan JB
    Healthc Financ Manage; 1998 Feb; 52(2):44-5. PubMed ID: 10176448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPOs: key part of the Medicare solution.
    Elden D
    Health Care Innov; 1995; 5(3):10, 39-40. PubMed ID: 10150794
    [No Abstract]   [Full Text] [Related]  

  • 34. Preferred provider organizations: issues for employers.
    Ermann D; deLissovoy G; Gabel J; Rice T
    Health Care Manage Rev; 1986; 11(4):29-36. PubMed ID: 3793471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The preferred provider organization development process: models for applying a systematic approach.
    Jackovitz DS
    Health Care Strateg Manage; 1984 Oct; 2(10):18-22. PubMed ID: 10299737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of preferred provider organizations.
    Guthrie MB
    J Med Pract Manage; 1985 Jul; 1(1):38-43. PubMed ID: 10281817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPOs: forces which will determine their growth and future.
    Cates NR
    Health Matrix; 1987; 5(3):3-8. PubMed ID: 10285384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health-insurance products and plan options.
    Youkstetter WD
    Am J Hosp Pharm; 1990 Oct; 47(10):2265-9. PubMed ID: 2248267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does competition by health maintenance organizations affect the adoption of cost-containment measures by fee-for-service plans?
    Joesch JM; Wickizer TM; Feldstein PJ
    Am J Manag Care; 1998 Jun; 4(6):832-8. PubMed ID: 10181069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.